Silvia Perez Protto, MD, MS, MBA

Silvia Perez-Protto, MD, MS, MBA is a staff at the Intensive Care and Resuscitation Department at the Cleveland Clinic, and Associate Professor of Anesthesiology at the Cleveland Clinic Learner College of Medicine. She is the medical director of the End of Life Center at the Office of Safety, Quality and Patient Experience at the Cleveland Clinic. She is the medical director of Lifebanc Organ Procurement Organization.

Dr. Perez-Protto earned her medical degree and post-graduate intensive care medicine degree from Universidad de la República, Montevideo-Uruguay.

She worked as an intensivist and transplant coordinator, conducting more than 100 organ donation interviews before relocating to the US in 2006. She was a Fundación Carolina scholar in 2005 at the Transplant Services Foundation, Clinic Hospital Universitat de Barcelona, Spain. She earned the ECFMG certificate and completed her post-graduate training including anesthesiology residency and critical care fellowship at the Cleveland Clinic.

Dr. Perez-Protto served as the president of the Ohio Chapter of the Society of Critical Care Medicine from 2018-2020 and was inducted as a fellow of the American College of Critical Care Medicine in 2021.

Dr. Perez-Protto has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at several professional association meetings. She served on the Cleveland Clinic Bioethics Committee for 5 years and as teaching faculty at the Center for Excellence in Healthcare Communication for 4 years. She led the opening of the Intensive Care Unit at the Cleveland Clinic Lutheran Hospital and served as the medical director until 2023. She served as the president of the Women Professional Staff Association 2023-2025.

As the medical director of the End of Life Center, Dr. Perez-Protto has designed and implemented the Advance Care Planning program at the Cleveland Clinic, with the ultimate goal of delivering goal-concordant care. She has co-led the implementation of “The Pause” to honor the person who dies at the hospital and the care provided by the healthcare team. She has co-created "The Pause" App and Death over Dinner for Healthcare to foster caregiver resilience related to end of life care.

Dr. Perez-Protto has designed and co-implemented an innovative program providing critical care services to Lifebanc Organ Procurement Organization, to optimize the detection and management of organ donors.

Education & Professional Highlights

Appointed
2013

Education & Fellowships

Graduate School - Baldwin Wallace University
Healthcare Management
Berea,
2022

Graduate School - Drexel University
Clinical Research for Medical Professionals
Philadelphia, PA
2017

Fellowship - Cleveland Clinic
Critical Care Anesthesiology
Cleveland, OH
2014

Residency - Cleveland Clinic
Anesthesiology
Cleveland, OH
2013

Residency - Cleveland Clinic
Pre-Resident Anesthesiology Non ACGME
Cleveland, OH
2009

Fellowship - Cleveland Clinic
Clinical Research Fellow
Cleveland, OH
2008

Residency - Hospital de Clinicas
Critical Care Medicine
Montevideo, Uruguay
2001

Medical Education - Universidad de la Republica Montevideo Facultad de Medicina
Montevideo, Uruguay
1997

Additional Training

Master of Science - Drexel University
Master of Business Administration - Baldwin Wallace University

Certifications

Anesthesiology
Anesthesiology - Critical Care Medicine

Specialty Interests

Critical Care Medicine. Advance Directives. Advance Care Planning. End of life care. Healthcare communication. Organ donor management

Research & Publications

See publications for Silvia Perez Protto, MD, MS, MBA.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/2/2024, Dr. Perez Protto has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Coming to a Cleveland Clinic location?

Silvia Perez Protto, MD, MS, MBA

Primary Location

Cleveland Clinic Main Campus

Additional Locations

Insurance

Is Cleveland Clinic Part of Your Insurance?

About Silvia Perez Protto, MD, MS, MBA